Scientists at the Medical University of South Carolina (MUSC) have found that a class of heart failure drugs might decrease low-density lipoprotein (LDL) cholesterol levels in patients who do not respond to statins. In a ...
Apr 6, 2017
0
9
If you've ever have the misfortune of a heart attack or are considered at risk of heart disease or stroke, your doctor will probably prescribe a statin drug, such as atorvastatin (Lipitor), to lower your blood cholesterol ...
Sep 7, 2016
0
12
When a powerful pair of cholesterol-lowering drugs first hit the market last summer, initial excitement in the medical community quickly turned to panic.
Apr 20, 2016
1
6
Standard treatment for prostate cancer can include chemotherapy that targets receptors on cancer cells. However, drug-resistant cancer cells can emerge during chemotherapy, limiting its effectiveness as a cancer-fighting ...
Apr 14, 2016
0
5
Researchers found that Fenofibrate, a drug used to reduce cholesterol levels in patients at risk of cardiovascular disease, is up to four times easier to deliver when the cholesterol concentration is at the levels of a healthy ...
Jan 14, 2016
0
0
Merck & Co. said Friday that it will continue a huge patient study of an experimental cholesterol medicine, the last one standing in a once-promising class of drugs being developed to prevent heart attacks, after an independent ...
Nov 13, 2015
0
21
The new statin alternatives, the class of drugs known as PCSK9 inhibitors, which are just coming onto the market, are a welcome addition for treating high cholesterol, said Stanley F. Fernandez, MD, PhD, assistant professor ...
Sep 9, 2015
0
6
Amgen Inc. has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades.
Aug 28, 2015
0
57
Ischemic heart disease is the leading cause of death in the world and second in Japan behind cancer. It causes blood vessels to become clogged or narrowed through the buildup of cholesterol plaque along the inside of artery ...
Jul 30, 2015
0
20
US regulators on Friday approved a new cholesterol drug called Praluent, made by Sanofi and Regeneron, for people with certain genetic risk factors for heart disease.
Jul 25, 2015
0
10
